February 13, 2019
The since-closed Washington boutique food and drug firm Buc & Beardsley LLP helped shield Indian pharmaceutical company Ranbaxy from regulatory scrutiny, according to a lawsuit filed Wednesday in Boston federal court that alleges Ranbaxy carried out a criminal enterprise that cost indirect purchasers millions.